TrialAntimicrobial agents and chemotherapy2013

Randomized trial of the virologic response during up to two years of entecavir-adefovir combination therapy in multiple-drug-refractory chronic hepatitis B virus patients.

Young-Suk Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.